packageCabazitaxel

cabazitaxel

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Cabazitaxel is a taxane anticancer drug used to treat prostate cancer, including castration-resistant disease. It is authorised in the European Union and used in cancer care, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q412963 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:cabazitaxel
ATC codes:L01CD04
DrugBank:DB06772
PubChem CID:9854073
ChEBI:63584
Wikidata:Q412963
formula:C45H57NO14
molar mass:835.944 g/mol (PubChem CID 9854073)
logP:2.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown